Natural angiotensin converting enzyme inhibitors: A safeguard against hypertension, respiratory distress syndrome, and chronic kidney diseases
Phytotherapy Research · 2023-12 · 37 (12) · 5464-5472
DOI: 10.1002/ptr.7987 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Phytotherapy Research, online erschienen am 07.09.2023. Verfasst von Aya Khaled und 10 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacognosy Department, Faculty of Pharmacy, Heliopolis University, Cairo, Egypt. Hauptthemen laut MEDLINE: Hypertension, Renal Insufficiency, Chronic, Respiratory Distress Syndrome. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 45 Literaturangaben.
Abstract (Originalsprache)
Hypertension is a serious concern as it is one of the causes of kideny failure and pulmonary fibrosis. An important therapeutic strategy for treating chronic hypertension is to inhibit the angiotensin converting enzyme (ACE). ACE inhibition reduces kidney damage, pulmonary artery pressure, and high blood pressure. Due to their high efficacy and low risk of side effects, natural renin‐angiotensin system inhibitors have drawn increasing attention over the past decades. Alkaloids, amino acids, anthocyanidins, flavonoids, glucosinolates, isoflavonoids, phenolic acids, polyphenolics, and triterpenoids are among the bioactive metabolites pocessing an impressive ACE inhibitory activity. Many herbs including Rosmarinus officinalis , Hibiscus sabdariffa , Curcuma longa , Rauwolfia serpentina , Emblica officinalis , Cynara scolymus , Punica granatum , Mucuna pruriens , Capsicum annuum , and Moringa olifera were found having ACE inhibitory activities comparable to captopril and enalpril. These enticing natural ACE inhibitors deserve to be a safeguard medicine against hypertension, respiratory distress syndrome, and chronic kidney diseases. More clinical trials are required before new natural compounds and herbs can be used to treat chronic hypertension and its ramifications, such as respiratory distress syndrome and kidney failure.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pharmacognosy Department, Faculty of Pharmacy, Heliopolis University, Cairo, Egypt.
- School of Pharmacy, University of Camerino, Camerino, Italy.
- Pharmacognosy Department, Faculty of Pharmacy, Cairo University, Cairo, Egypt.
- Department of Pharmaceutical Sciences, College of Pharmacy, Gulf Medical University, Ajman, United Arab Emirates.
ORCID-Profile: Omar M Sabry
Zitieren
APA
Khaled, A., Ahmed, E., Mamdouh, M., Saad, H., Mohamed, A., Sobhy, M., Piatti, D., Sabry, M., Saad, M. A., Sabry, O. M., & Caprioli, G. (2023). Natural angiotensin converting enzyme inhibitors: A safeguard against hypertension, respiratory distress syndrome, and chronic kidney diseases. Phytotherapy Research, 37(12), 5464-5472. https://doi.org/10.1002/ptr.7987
Vancouver
Khaled A, Ahmed E, Mamdouh M, Saad H, Mohamed A, Sobhy M, et al. Natural angiotensin converting enzyme inhibitors: A safeguard against hypertension, respiratory distress syndrome, and chronic kidney diseases. Phytotherapy Research. 2023;37(12):5464-5472. doi:10.1002/ptr.7987
BibTeX
@article{Khaled2023,
author = {Khaled, Aya and Ahmed, Esraa and Mamdouh, Mohamed and Saad, Hager and Mohamed, Aya and Sobhy, Marina and Piatti, Diletta and Sabry, Miral and Saad, Muhammed A and Sabry, Omar M and Caprioli, Giovanni},
title = {Natural angiotensin converting enzyme inhibitors: A safeguard against hypertension, respiratory distress syndrome, and chronic kidney diseases},
journal = {Phytotherapy Research},
year = {2023},
volume = {37},
number = {12},
pages = {5464--5472},
doi = {10.1002/ptr.7987}
}
EUVIMED